2,988 results on '"Santini, D"'
Search Results
2. Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies
3. Communication and support of patients and caregivers in chronic cancer care: ESMO Clinical Practice Guideline
4. Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
5. ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer
6. Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
7. Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline
8. KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma
9. Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
10. Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline
11. Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data
12. Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials
13. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
14. Role of molecular genetics in the clinical management of cholangiocarcinoma
15. Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer
16. Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study
17. Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
18. The role of androgen response pathway in association with tumor biology and response to neoadjuvant Immune-Checkpoint Inhibitors (ICI) in Muscle-Invasive urothelial Bladder Carcinoma (MIBC)
19. Clinical Application of Bladder MRI and Vesical Imaging-Reporting And Data System
20. Diagnostic accuracy and inter-reader agreement of nac-VIRADS scoring system: A prospective validation study
21. The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies
22. Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study
23. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
24. Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
25. Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System.
26. Bone health in cancer: ESMO Clinical Practice Guidelines
27. Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review
28. Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment†
29. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
30. Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics
31. Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes
32. Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study
33. Tumor Response by Baseline Metastases in Patients (Pts) With Renal Cell Carcinoma (RCC) Treated with Lenvatinib (L) Plus Pembrolizumab (P) vs Sunitinib (S): Post Hoc Analysis of the CLEAR Trial
34. 1903P Tumor response by baseline metastases in patients (pts) with renal cell carcinoma (RCC) treated with lenvatinib (L) plus pembrolizumab (P) vs sunitinib (S): Post hoc analysis of the CLEAR trial
35. The use of SAMe in chemotherapy-induced liver injury
36. Bone metastases in biliary cancers: A multicenter retrospective survey
37. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
38. The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
39. Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials
40. 236P Trastuzumab deruxtecan in Italian real-world experience: Updated analysis from DE-REAL study
41. 224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study
42. Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type circulating tumor DNA : Individual patient data pooled analysis of CRICKET and CAVE trials
43. OC.15.2 SMALL BOWEL CARCINOMAS MAY COMPLICATE COELIAC DISEASE DESPITE STRICT ADHERENCE TO GLUTEN-FREE DIET: A CASE SERIES FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM
44. PC.01.9 HYPOMETHYLATION OF LINE-1 IN SMALL BOWEL CARCINOMAS AND COELIAC DISEASE
45. Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience
46. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
47. Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics
48. PATHOLOGIC FINDINGS IN RISK-REDUCING SALPINGO-OOPHORECTOMY (RRSO) IN WOMEN WITH BRCA1 OR BRCA2 MUTATIONS: A SINGLE CENTER EXPERIENCE: EP827
49. 101P Pharmacological inhibition of glyoxalase-1 as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models
50. Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.